NANOG and neoplasm: Targeting NANOG in head and neck squamous cell carcinoma-derived spheroid cells significantly inhibits tumor aggressiveness and increases chemosensitivity to cisplatin (57); perhaps targeting NANOG within mHNcSCC would have a similar effect on these parameters.